Cyteir Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Cyteir Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cyteir Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Cyteir Therapeutics by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.1M | 687k | 3.04 |
2023-09-30 | $1.8M | 641k | 2.84 |
2023-06-30 | $1.5M | 585k | 2.60 |
2023-03-31 | $1.1M | 585k | 1.82 |
2022-12-31 | $965k | 585k | 1.65 |
2022-06-30 | $1.8M | 612k | 2.99 |
2022-03-31 | $1.5M | 385k | 3.77 |
2021-09-30 | $6.0M | 341k | 17.55 |
2021-06-30 | $1.5M | 70k | 21.14 |
Top funds holding Cyteir Therapeutics
View all funds holding Cyteir Therapeutics